SlideShare a Scribd company logo
1 of 41
Foundations in Microbiology
Chapter
17
PowerPoint to accompany
Fifth Edition
Talaro
Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
2
Disorders in Immunity
Chapter 17
3
Immunopathology
• Allergy, hypersensitivity – an exaggerated,
misdirected expression of immune responses
• Involves the same types of immune reactions as
those at work in protective immunities.
• Autoimmunity – abnormal responses to self Ag
• Immunodeficiency – deficiency or loss of
immunity
• Cancer – results from a lack of surveillance
4
5
6
Type I Hypersensitivity
• Atopy – any chronic local allergy such as
hay fever or asthma
• Anaphylaxis – a systemic, often explosive
reaction that involves airway obstruction
and circulatory collapse
7
Mechanism of Type I
• sensitizing dose – on first contact with allergen,
specific B cells form IgE which attaches to mast
cells and basophils
• provocative dose - subsequent exposure with the
same allergen binds to the IgE-mast cell complex
• degranulation releases mediators with
physiological effects such as vasodilation and
bronchoconstriction
• symptoms are rash, itching, redness, increased
mucous discharge, pain, swelling, and difficulty
breathing
8
9
Role of Mast Cells & Basophils
• Mast cells are located in the connective tissue
of virtually all organs; high conc. in lungs,
skin, GI and genital tract
• Basophils circulate in blood, migrate into
tissues
• each cell can bind 10,000-40,000 IgE
• cytoplasmic granules contain physiologically
active cytokines, histamine, etc
• cells degranulate when stimulated by allergen
10
Chemical mediators
11
12
Systemic Anaphylaxis
• Sudden respiratory and circulatory
disruption that can be fatal in a few minutes
• Allergen and route are variable
• Bee stings, antibiotics or serum injection
13
Strategies for circumventing allergic
attacks
14
Blocking Ab
15
Type II Hypersensitivity
• Reactions that lyse foreign cells
• Involve antibodies, complement, leading to
lysis of foreign cells
• Transfusion reactions
– ABO blood groups
– Rh factor – hemolytic disease of the newborn
16
17
18
19
20
Type III Hypersensitivity
• A large quantity of soluble foreign Ag
stimulates Ab that produce small, soluble
Ag-Ab complexes
• Immune complexes become trapped in
tissues & incite a damaging inflammatory
response
– Arthus reaction – local reaction to series of
injected Ag to same body site
– Serum sickness – systemic disease resulting
from repeated injections of foreign proteins
21
22
Autoimmunity
• In certain type I & II hypersensitivities, the immune
system has lost tolerance to self molecules and
forms autoantibodies and sensitized T cells against
them.
• More common in females
• Disruption of function can be systemic or organic
specific
– Systemic lupus erythematosus
– Rheumatoid arthritis
– Endocrine autoimmunities
– Myasthenia gravis
– Multiple sclerosis
23
24
25
26
27
Type IV Hypersensitivity
• Cell-mediated
• A delayed response to Ag involving activation of
and damage by T cells
• Delayed allergic response – skin response to
allergens – tuberculin skin test, contact dermititis
from plants, metals, cosmetics
• Graft rejection – reaction of cytotoxic T cells
directed against foreign cells of a grafted tissue;
involves recognition of foreign HLA
28
29
30
31
Immunodeficiency diseases
• Components of the immune response system are absent.
Deficiencies involve B and T cells, phagocytes, and
complement
– Primary immunodeficiency – genetically based
congenital lack of B-cell and/or T cell activity
– B cell defect – agammaglobulinemia – patient lacks
antibodies
– T cell defect – thymus is missing or abnormal
– Severe combined immunodeficiency - both limbs of
lymphocyte system are missing or defective; no
adaptive immune response
– Secondary (acquired) immune deficiency – due to
damage after birth (infections, drugs, radiation) AIDS
32
33
Cancer
• Overgrowth of abnormal tissue arises due to
malfunction of immune surveillance
• Tumors may be benign (nonspreading) or
malignant (a cancer) that spreads from tissue of
origin to other sites
• Malignant tumors may be
– carcinomas originate from epithelial tissue
– sarcomas originate from embryonic connective tissue
• Cancers occur in nearly every cell type
34
Characteristics of cancerous growths
• Disorganized behavior and independence
from surrounding normal tissues
• Permanent loss of cell differentiation
• Expression of special markers on their
surface
35
Interrelationship between genes and
cancer
1. Cancer cell often have damaged chromosomes
2. A specific alteration in a gene can lead to cancer
3. Predisposition for some cancers is inherited
4. Rates of cancer are highest in individuals who
cannot repair damaged DNA
5. Mutagenic agents cause cancer
6. Cells contain genes that can be transformed to
cancer-causing oncogenes
7. Tumor-supressor genes exist in the normal
genome
36
Mechanism of Cancer
• Some type of gene alteration turns a normal
gene (proto-oncogene) that regulates the
onset of mitosis into an oncogene
• The oncogene overrides normal mitotic
controls and cause the cell to divide
continuously
• Tumor suppressor genes may be missing or
inactivated
37
38
Role of viruses in cancer
• Some viruses carry oncogenes whose
products cause transformation of host cells
into cancer cells
• Viral genome may be inserted into
regulatory sites
• Human papillomavirus cervical cancer
• Epstein-Barr virus – Burkitt’s lymphoma
39
40
41
Function of immune system in
cancer
• Cells with cancer-causing potential arise
constantly in the body but the immune system
normally discovers and destroys them
• Cell-mediated immunity, TC, NK & macrophages,
antibodies
• Immune system fails in cancer
– may not be immunogenic enough
– may retain self-markers and not be targeted
• Maybe a slight or transient failure allows cancer to
develop

More Related Content

What's hot

Hypersensitivity reactions lecture notes
Hypersensitivity reactions lecture notesHypersensitivity reactions lecture notes
Hypersensitivity reactions lecture notes
Bruno Mmassy
 

What's hot (19)

Immunopathology
ImmunopathologyImmunopathology
Immunopathology
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
 
Antibiotic
AntibioticAntibiotic
Antibiotic
 
Hypersensitivity reactions lecture notes
Hypersensitivity reactions lecture notesHypersensitivity reactions lecture notes
Hypersensitivity reactions lecture notes
 
Immune system : assessment
Immune system : assessmentImmune system : assessment
Immune system : assessment
 
Immunopathology
ImmunopathologyImmunopathology
Immunopathology
 
Immunopathology 1
Immunopathology 1Immunopathology 1
Immunopathology 1
 
Autoimmunity - Microbiology - Immunology - Dr.Someshwaran Rajamani December 2015
Autoimmunity - Microbiology - Immunology - Dr.Someshwaran Rajamani December 2015Autoimmunity - Microbiology - Immunology - Dr.Someshwaran Rajamani December 2015
Autoimmunity - Microbiology - Immunology - Dr.Someshwaran Rajamani December 2015
 
Hypersensitivity
HypersensitivityHypersensitivity
Hypersensitivity
 
Hypersensitivity
HypersensitivityHypersensitivity
Hypersensitivity
 
Immune System: Immunocytology, Immunophysiology and Intro to Immunopathology
 Immune System: Immunocytology, Immunophysiology and Intro to Immunopathology  Immune System: Immunocytology, Immunophysiology and Intro to Immunopathology
Immune System: Immunocytology, Immunophysiology and Intro to Immunopathology
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
 
Hypersensitity, And Types of Hypersensitivity I, II, III, IV
Hypersensitity, And Types of Hypersensitivity I, II, III, IVHypersensitity, And Types of Hypersensitivity I, II, III, IV
Hypersensitity, And Types of Hypersensitivity I, II, III, IV
 
Autoimmune diseases
Autoimmune diseasesAutoimmune diseases
Autoimmune diseases
 
Immunological tolerance
Immunological toleranceImmunological tolerance
Immunological tolerance
 
Hypersensitivity type -3 reactions
Hypersensitivity type -3 reactions Hypersensitivity type -3 reactions
Hypersensitivity type -3 reactions
 
Molecular mimicry
Molecular mimicryMolecular mimicry
Molecular mimicry
 
Hypersesnsitivity
HypersesnsitivityHypersesnsitivity
Hypersesnsitivity
 
Autoimmunity - pathophysiology (pharm D)
Autoimmunity - pathophysiology (pharm D)Autoimmunity - pathophysiology (pharm D)
Autoimmunity - pathophysiology (pharm D)
 

Similar to Disorders in-immunity3448

DR.VANDANA LAST CLASS (1).pptx
DR.VANDANA  LAST CLASS (1).pptxDR.VANDANA  LAST CLASS (1).pptx
DR.VANDANA LAST CLASS (1).pptx
VandanaChandan1
 
Allergy & Hypersensitivity type I-2023.ppt
Allergy & Hypersensitivity type I-2023.pptAllergy & Hypersensitivity type I-2023.ppt
Allergy & Hypersensitivity type I-2023.ppt
Dr. Farshid Saadat
 

Similar to Disorders in-immunity3448 (20)

HYPERSENSITIVITY
HYPERSENSITIVITYHYPERSENSITIVITY
HYPERSENSITIVITY
 
DR.VANDANA LAST CLASS (1).pptx
DR.VANDANA  LAST CLASS (1).pptxDR.VANDANA  LAST CLASS (1).pptx
DR.VANDANA LAST CLASS (1).pptx
 
Hypersenstivity
HypersenstivityHypersenstivity
Hypersenstivity
 
Hypersensitivity
HypersensitivityHypersensitivity
Hypersensitivity
 
Ch 43 immunity
Ch 43 immunityCh 43 immunity
Ch 43 immunity
 
Immunopharmacology & immunology Unit-1 (PC-660)
Immunopharmacology & immunology Unit-1  (PC-660)Immunopharmacology & immunology Unit-1  (PC-660)
Immunopharmacology & immunology Unit-1 (PC-660)
 
Allergy & Hypersensitivity type I-2023.ppt
Allergy & Hypersensitivity type I-2023.pptAllergy & Hypersensitivity type I-2023.ppt
Allergy & Hypersensitivity type I-2023.ppt
 
6. autoimmune diseases
6. autoimmune diseases6. autoimmune diseases
6. autoimmune diseases
 
Hypersensitivity reactions BY GROUP 1.pptx
Hypersensitivity reactions BY GROUP 1.pptxHypersensitivity reactions BY GROUP 1.pptx
Hypersensitivity reactions BY GROUP 1.pptx
 
Immunity THE BODY’S DEFENSES
Immunity  THE BODY’S DEFENSESImmunity  THE BODY’S DEFENSES
Immunity THE BODY’S DEFENSES
 
Hypersensitivity
HypersensitivityHypersensitivity
Hypersensitivity
 
Chronic inflammation
Chronic inflammationChronic inflammation
Chronic inflammation
 
Hypersensitivity or allergic reactions
Hypersensitivity or allergic reactionsHypersensitivity or allergic reactions
Hypersensitivity or allergic reactions
 
Immunology.ppt
Immunology.pptImmunology.ppt
Immunology.ppt
 
Hypersensitivity and autoimmune diseases
Hypersensitivity and autoimmune diseasesHypersensitivity and autoimmune diseases
Hypersensitivity and autoimmune diseases
 
1 Hypersensitivity RXN.pptx
1 Hypersensitivity RXN.pptx1 Hypersensitivity RXN.pptx
1 Hypersensitivity RXN.pptx
 
Immunity to bacteria and related organisms in animal
Immunity to bacteria and related organisms in animalImmunity to bacteria and related organisms in animal
Immunity to bacteria and related organisms in animal
 
Agents affecting immune system
Agents affecting immune systemAgents affecting immune system
Agents affecting immune system
 
Hypersensitivity-Team1.ppt
Hypersensitivity-Team1.pptHypersensitivity-Team1.ppt
Hypersensitivity-Team1.ppt
 
Hypersensitivity.ppt
Hypersensitivity.pptHypersensitivity.ppt
Hypersensitivity.ppt
 

More from Cleophas Rwemera

More from Cleophas Rwemera (20)

Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891
 
Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892
 
Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892
 
Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01
 
Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02
 
Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02
 
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
 
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
 
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
 
Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02
 
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
 
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
 
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
 
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
 
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
 
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
 
Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01
 
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
 
Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02
 
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
 

Recently uploaded

Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
EADTU
 
SPLICE Working Group: Reusable Code Examples
SPLICE Working Group:Reusable Code ExamplesSPLICE Working Group:Reusable Code Examples
SPLICE Working Group: Reusable Code Examples
Peter Brusilovsky
 
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
中 央社
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
AnaAcapella
 

Recently uploaded (20)

An Overview of the Odoo 17 Knowledge App
An Overview of the Odoo 17 Knowledge AppAn Overview of the Odoo 17 Knowledge App
An Overview of the Odoo 17 Knowledge App
 
Including Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdfIncluding Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdf
 
Supporting Newcomer Multilingual Learners
Supporting Newcomer  Multilingual LearnersSupporting Newcomer  Multilingual Learners
Supporting Newcomer Multilingual Learners
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
 
diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....
 
8 Tips for Effective Working Capital Management
8 Tips for Effective Working Capital Management8 Tips for Effective Working Capital Management
8 Tips for Effective Working Capital Management
 
DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUM
DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUMDEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUM
DEMONSTRATION LESSON IN ENGLISH 4 MATATAG CURRICULUM
 
Spring gala 2024 photo slideshow - Celebrating School-Community Partnerships
Spring gala 2024 photo slideshow - Celebrating School-Community PartnershipsSpring gala 2024 photo slideshow - Celebrating School-Community Partnerships
Spring gala 2024 photo slideshow - Celebrating School-Community Partnerships
 
SPLICE Working Group: Reusable Code Examples
SPLICE Working Group:Reusable Code ExamplesSPLICE Working Group:Reusable Code Examples
SPLICE Working Group: Reusable Code Examples
 
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
 
Mattingly "AI & Prompt Design: Named Entity Recognition"
Mattingly "AI & Prompt Design: Named Entity Recognition"Mattingly "AI & Prompt Design: Named Entity Recognition"
Mattingly "AI & Prompt Design: Named Entity Recognition"
 
Book Review of Run For Your Life Powerpoint
Book Review of Run For Your Life PowerpointBook Review of Run For Your Life Powerpoint
Book Review of Run For Your Life Powerpoint
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
 
Andreas Schleicher presents at the launch of What does child empowerment mean...
Andreas Schleicher presents at the launch of What does child empowerment mean...Andreas Schleicher presents at the launch of What does child empowerment mean...
Andreas Schleicher presents at the launch of What does child empowerment mean...
 
Basic Civil Engineering notes on Transportation Engineering & Modes of Transport
Basic Civil Engineering notes on Transportation Engineering & Modes of TransportBasic Civil Engineering notes on Transportation Engineering & Modes of Transport
Basic Civil Engineering notes on Transportation Engineering & Modes of Transport
 
MOOD STABLIZERS DRUGS.pptx
MOOD     STABLIZERS           DRUGS.pptxMOOD     STABLIZERS           DRUGS.pptx
MOOD STABLIZERS DRUGS.pptx
 
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
 
VAMOS CUIDAR DO NOSSO PLANETA! .
VAMOS CUIDAR DO NOSSO PLANETA!                    .VAMOS CUIDAR DO NOSSO PLANETA!                    .
VAMOS CUIDAR DO NOSSO PLANETA! .
 
How to Send Pro Forma Invoice to Your Customers in Odoo 17
How to Send Pro Forma Invoice to Your Customers in Odoo 17How to Send Pro Forma Invoice to Your Customers in Odoo 17
How to Send Pro Forma Invoice to Your Customers in Odoo 17
 
Graduate Outcomes Presentation Slides - English (v3).pptx
Graduate Outcomes Presentation Slides - English (v3).pptxGraduate Outcomes Presentation Slides - English (v3).pptx
Graduate Outcomes Presentation Slides - English (v3).pptx
 

Disorders in-immunity3448

  • 1. Foundations in Microbiology Chapter 17 PowerPoint to accompany Fifth Edition Talaro Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
  • 3. 3 Immunopathology • Allergy, hypersensitivity – an exaggerated, misdirected expression of immune responses • Involves the same types of immune reactions as those at work in protective immunities. • Autoimmunity – abnormal responses to self Ag • Immunodeficiency – deficiency or loss of immunity • Cancer – results from a lack of surveillance
  • 4. 4
  • 5. 5
  • 6. 6 Type I Hypersensitivity • Atopy – any chronic local allergy such as hay fever or asthma • Anaphylaxis – a systemic, often explosive reaction that involves airway obstruction and circulatory collapse
  • 7. 7 Mechanism of Type I • sensitizing dose – on first contact with allergen, specific B cells form IgE which attaches to mast cells and basophils • provocative dose - subsequent exposure with the same allergen binds to the IgE-mast cell complex • degranulation releases mediators with physiological effects such as vasodilation and bronchoconstriction • symptoms are rash, itching, redness, increased mucous discharge, pain, swelling, and difficulty breathing
  • 8. 8
  • 9. 9 Role of Mast Cells & Basophils • Mast cells are located in the connective tissue of virtually all organs; high conc. in lungs, skin, GI and genital tract • Basophils circulate in blood, migrate into tissues • each cell can bind 10,000-40,000 IgE • cytoplasmic granules contain physiologically active cytokines, histamine, etc • cells degranulate when stimulated by allergen
  • 11. 11
  • 12. 12 Systemic Anaphylaxis • Sudden respiratory and circulatory disruption that can be fatal in a few minutes • Allergen and route are variable • Bee stings, antibiotics or serum injection
  • 15. 15 Type II Hypersensitivity • Reactions that lyse foreign cells • Involve antibodies, complement, leading to lysis of foreign cells • Transfusion reactions – ABO blood groups – Rh factor – hemolytic disease of the newborn
  • 16. 16
  • 17. 17
  • 18. 18
  • 19. 19
  • 20. 20 Type III Hypersensitivity • A large quantity of soluble foreign Ag stimulates Ab that produce small, soluble Ag-Ab complexes • Immune complexes become trapped in tissues & incite a damaging inflammatory response – Arthus reaction – local reaction to series of injected Ag to same body site – Serum sickness – systemic disease resulting from repeated injections of foreign proteins
  • 21. 21
  • 22. 22 Autoimmunity • In certain type I & II hypersensitivities, the immune system has lost tolerance to self molecules and forms autoantibodies and sensitized T cells against them. • More common in females • Disruption of function can be systemic or organic specific – Systemic lupus erythematosus – Rheumatoid arthritis – Endocrine autoimmunities – Myasthenia gravis – Multiple sclerosis
  • 23. 23
  • 24. 24
  • 25. 25
  • 26. 26
  • 27. 27 Type IV Hypersensitivity • Cell-mediated • A delayed response to Ag involving activation of and damage by T cells • Delayed allergic response – skin response to allergens – tuberculin skin test, contact dermititis from plants, metals, cosmetics • Graft rejection – reaction of cytotoxic T cells directed against foreign cells of a grafted tissue; involves recognition of foreign HLA
  • 28. 28
  • 29. 29
  • 30. 30
  • 31. 31 Immunodeficiency diseases • Components of the immune response system are absent. Deficiencies involve B and T cells, phagocytes, and complement – Primary immunodeficiency – genetically based congenital lack of B-cell and/or T cell activity – B cell defect – agammaglobulinemia – patient lacks antibodies – T cell defect – thymus is missing or abnormal – Severe combined immunodeficiency - both limbs of lymphocyte system are missing or defective; no adaptive immune response – Secondary (acquired) immune deficiency – due to damage after birth (infections, drugs, radiation) AIDS
  • 32. 32
  • 33. 33 Cancer • Overgrowth of abnormal tissue arises due to malfunction of immune surveillance • Tumors may be benign (nonspreading) or malignant (a cancer) that spreads from tissue of origin to other sites • Malignant tumors may be – carcinomas originate from epithelial tissue – sarcomas originate from embryonic connective tissue • Cancers occur in nearly every cell type
  • 34. 34 Characteristics of cancerous growths • Disorganized behavior and independence from surrounding normal tissues • Permanent loss of cell differentiation • Expression of special markers on their surface
  • 35. 35 Interrelationship between genes and cancer 1. Cancer cell often have damaged chromosomes 2. A specific alteration in a gene can lead to cancer 3. Predisposition for some cancers is inherited 4. Rates of cancer are highest in individuals who cannot repair damaged DNA 5. Mutagenic agents cause cancer 6. Cells contain genes that can be transformed to cancer-causing oncogenes 7. Tumor-supressor genes exist in the normal genome
  • 36. 36 Mechanism of Cancer • Some type of gene alteration turns a normal gene (proto-oncogene) that regulates the onset of mitosis into an oncogene • The oncogene overrides normal mitotic controls and cause the cell to divide continuously • Tumor suppressor genes may be missing or inactivated
  • 37. 37
  • 38. 38 Role of viruses in cancer • Some viruses carry oncogenes whose products cause transformation of host cells into cancer cells • Viral genome may be inserted into regulatory sites • Human papillomavirus cervical cancer • Epstein-Barr virus – Burkitt’s lymphoma
  • 39. 39
  • 40. 40
  • 41. 41 Function of immune system in cancer • Cells with cancer-causing potential arise constantly in the body but the immune system normally discovers and destroys them • Cell-mediated immunity, TC, NK & macrophages, antibodies • Immune system fails in cancer – may not be immunogenic enough – may retain self-markers and not be targeted • Maybe a slight or transient failure allows cancer to develop